|
Quotes & Info
|
| SNTA > SEC Filings for SNTA > Form 8-K on 13-Mar-2013 | All Recent SEC Filings |
13-Mar-2013
Other Events, Financial Statements and Exhibits
On March 13, 2013, Synta Pharmaceuticals Corp. ("Synta") issued a press release announcing the appointment of Dr. Sumant Ramachandra as President, Research and Development. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits. Exhibit Number Description 99.1 Press Release, dated March 13, 2013. |
|
|